发明名称 |
Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
摘要 |
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e.g. an Androstane steroid, or a pharmaceutical composition containing a semiochemical, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids. |
申请公布号 |
AU5350494(A) |
申请公布日期 |
1995.01.03 |
申请号 |
AU19940053504 |
申请日期 |
1993.09.28 |
申请人 |
PHERIN CORPORATION |
发明人 |
DAVID L. BERLINER;NATHAN WILLIAM ADAMS;CLIVE L JENNINGS-WHITE |
分类号 |
A61K31/56;A61K31/565;A61K31/568;A61P25/00;A61P25/18;A61P25/22;A61P25/24;C07J1/00 |
主分类号 |
A61K31/56 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|